The characterization of two human cervical carcinoma HeLa sublines resistant to cisplatin

Research in Experimental Medicine

Volumn 193, Issue 1, 1993, Pages 389-396

  Osmak, Maja ^a   Eljuga, Damir ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cell sublines; Cisplatin resistance; Cross resistance

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; SBS; UNCLASSIFIED DRUG; VINCRISTINE; VINCRISTINE SULFATE;

ARTICLE; DRUG RESISTANCE; HELA CELL; HUMAN; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; CELL SEPARATION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; HELA CELLS; HUMAN; METALLOTHIONEIN; SUPPORT, NON-U.S. GOV'T; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0027427681     PISSN: 03009130     EISSN: 14338580     Source Type: Journal    
DOI: 10.1007/BF02576247     Document Type: Article

References (28)

1. Inhibition of soluble glutathione S-transferase by diuretic drugs
2. Review: cellular pharmacology of cis-platin: perspectives on mechanisms of aquired resistance
3. Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells
4. Glutathione metabolism as a determinant of therapeutic efficacy: a review
5. Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein
6. Characterization of acquired resistance to cis-diamminedichloroplatinum-(II) in BE human colon carcinoma cells
7. Failure of chronic glutathione elevation to reduce cytotoxicity produced by exposure to cis-diamminedichloroplatinum (II), ionizing radiation, or hyperthermia
8. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-buthyl-homocysteine sulfoximine)
9. Metallothioneins1,2
10. Augmentation of Adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and-sensitive human ovarian carcinoma cell lines by butathione sulfoximine-mediated glutathione depletion
11. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum (II) in vitro
12. Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents
13. Metallothionein content correlates with sensitivity of human small cell lung cancer cell lines to cisplatin
14. Overexpression of metallothioneins confers resistance to anticancer drugs
15. cis-Diamminedichloroplatinum-(II)-resistant sublines derived from two human ovarian tumor cell lines
16. Ultraviolet radiation-induced metallothionein-I gene activation is associated with extensive DNA demethylation
17. Chemosensitivity testing of primary human renal cell carcinoma by the tetrazolium-based microculture assay (MTT)
18. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
19. Levels of glutathione transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin
20. Colalteral resistance or sensitivity of human larynx carcinoma HEp2 cells resistant to cis-dichlorodiammine-platinum(II) or vincristine sulfate
21. Glutathiome S-transferases: gene structure, regulation and biological function
22. Experession of recombinant glutathione S-transferase π, Ya or Yb1 confers resistance to alkylating agents
23. Multiple mechanisms of resistance to cis-dichlorodiammineplatinum(II) in murine leukemia L1210 cells
24. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of Chinese hamster
25. Cisplatin resistance in human cancer
26. Alkylating agents. In vitro studies of cross-resistance patterns in human lines
27. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II)
28. Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II)